Chapter title |
Potential Treatment Options in a Post-antibiotic Era
|
---|---|
Book title |
Infectious Diseases and Nanomedicine III
|
Published in |
Advances in experimental medicine and biology, January 2018
|
DOI | 10.1007/978-981-10-7572-8_5 |
Pubmed ID | |
Book ISBNs |
978-9-81-107571-1, 978-9-81-107572-8
|
Authors |
R R Bragg, C M Meyburgh, J-Y Lee, M Coetzee |
Abstract |
Following the Golden Age of antibiotic discovery in the previous century, the rate of antibiotic discovery has plummeted during the past 50 years while the incidence of antimicrobial resistance is ever-increasing. Presently, humankind is forced to address a major public health threat in the form of multiple drug resistance and urgent action is required to halt the advent of a post-antibiotic era. This chapter aims to draw the attention to the escalating global crisis of antimicrobial resistance fueled by the irresponsible use of antibiotics in healthcare and animal production sectors. The merits of alternative prevention and treatment options, including vaccines, herbal products, bacteriophages, and improved biosecurity measures are also discussed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 79 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 16% |
Student > Master | 9 | 11% |
Student > Bachelor | 8 | 10% |
Student > Ph. D. Student | 8 | 10% |
Student > Doctoral Student | 5 | 6% |
Other | 10 | 13% |
Unknown | 26 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 16% |
Biochemistry, Genetics and Molecular Biology | 13 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 8% |
Immunology and Microbiology | 6 | 8% |
Medicine and Dentistry | 5 | 6% |
Other | 4 | 5% |
Unknown | 32 | 41% |